Outset Medical Inc's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 112/206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 15.75.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Outset Medical Inc's Score
Industry at a Glance
Industry Ranking
112 / 206
Overall Ranking
268 / 4562
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
5
analysts
Buy
Current Rating
15.750
Target Price
+262.90%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Outset Medical Inc Highlights
StrengthsRisks
Outset Medical, Inc. is a medical technology company. It offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. It designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. Tablo Console is a proprietary, compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.
Overvalued
The company’s latest PE is -0.28, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 18.96M shares, increasing 9.22% quarter-over-quarter.
Outset Medical, Inc. is a medical technology company. It offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. It designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. Tablo Console is a proprietary, compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.
Ticker SymbolOM
CompanyOutset Medical Inc
CEOTrigg (Leslie L)
Websitehttps://outsetmedical.com/
FAQs
What is the current price of Outset Medical Inc (OM)?
The current price of Outset Medical Inc (OM) is 3.150.
What is the symbol of Outset Medical Inc?
The ticker symbol of Outset Medical Inc is OM.
What is the 52-week high of Outset Medical Inc?
The 52-week high of Outset Medical Inc is 25.350.
What is the 52-week low of Outset Medical Inc?
The 52-week low of Outset Medical Inc is 3.260.
What is the market capitalization of Outset Medical Inc?
The market capitalization of Outset Medical Inc is 56.10M.
What is the net income of Outset Medical Inc?
The net income of Outset Medical Inc is -127.98M.
Is Outset Medical Inc (OM) currently rated as Buy, Hold, or Sell?
According to analysts, Outset Medical Inc (OM) has an overall rating of Buy, with a price target of 15.750.
What is the Earnings Per Share (EPS TTM) of Outset Medical Inc (OM)?
The Earnings Per Share (EPS TTM) of Outset Medical Inc (OM) is -11.620.